You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 204451 - 204460 of 207728 results
  1. Synthetic Lubricating & Hydraulic Oil for Motion Control, Steam Turbines and Gears, Military Symbol 2190-TEP Replacement


    Existing MIL-PRF-17331 petroleum based fluids (military symbol 2190-TEP) no longer exhibit acceptable performance at the high performance levels required of Navy submarine platforms. The service life of fluids procured in accordance with MIL-PRF-17331 have experienced high depletion rates of fluid antioxidant (AO) additive packages, sharp increases in fluid Total Acid Number (TAN) and severe off-g ...

    SBIR Phase II 2005 Department of DefenseNavy
  2. Virtual Instructor Pilot Exercise Referee (VIPER) for CNATRA

    SBC: DISCOVERY MACHINE INC            Topic: SB052009

    It has long been established that the best way to learn is to have a private tutor who works with you one-on-one, adapting the training to your learning needs. In such a setting, one can: ask the tutor questions, get feedback on an approach to solving a problem, and suggestions on how to improve. Our objective in this proposal is to adapt VIPER, originally developed for the Airforce Education and ...

    SBIR Phase II 2019 Department of DefenseNavy
  3. A Novel Peptide Therapeutic for Obesity

    SBC: VIRTICI LLC            Topic: 300

    Project Summary The goal of this project is to develop a novel peptide therapeuticVTC Gfor the treatment of obesityTodayone third of adults in the United StatesUSare obesewith an estimated annual healthcare burden of approximately $billionByit is projected that overof adults in the US will be obese with a yearly healthcare burden expected to exceed $billionwhich will account for approximatelyof th ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Point of Care Attachment of Antibiotics onto Metal Implants

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of biofilms on device surfaces, not only necessitate new surgeries but in themselves present a significa ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Backup Landing System for Fire Scout (INAV-SL SBIR Phase 2.5 Enhancement)

    SBC: SCIENTIFIC SYSTEMS CO INC            Topic: N112127

    The primary objective of the proposed INAV-SL (Image Based Navigation for VTUAV Shipboard Landing) program is to provide an advanced image-based navigation system in response to Naval Air Systems Command (NAVAIR) (PMA-266) capability needs for a backup landing system for the MQ-8 Fire Scout Vertical Take-off and Landing (VTOL) Tactical Unmanned Aerial Vehicle (VTUAVT). The INAV-SL system utilizes ...

    SBIR Phase II 2019 Department of DefenseNavy
  6. Development Of Novel Diabetes Therapies Based On Neutralizing FSTL3 Activity

    SBC: Fairbanks Pharmaceuticals Inc            Topic: 200

    Both typeand typediabetes involve loss of insulin producing pancreaticcells resulting in inadequate insulin secretion to control blood glucoseand ultimately requiring daily insulin injections to avoid the constellation of life threatening complications that arise from long term hyperglycemiaWhile transplantation of cadaveric pancreatic islets that containcells has been successful for treating a sm ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Sherlock

    SBC: NOU SYSTEMS INC            Topic: MDA18011

    Sherlock enables a revolutionary capability for analysts' to collaborate and comprehend vast amounts of data in a zero-trust environment, and allows for creation of analysis pipelines and tools that are workflow-based and shareable across the enterprise. Integrating the tools into the MDA SoS M&S Enterprise will allow for automated calculation and presentation of relevant information, while retain ...

    SBIR Phase II 2022 Department of DefenseMissile Defense Agency
  8. Ultra-sensitive Singlet Oxygen Dosimeter for Skin Cancer Treatment and Prevention

    SBC: PHYSICAL SCIENCES INC.            Topic: 102

    Project Summary/AbstractSkin cancer is the most common form of cancer. Each year in the U.S. alone over 5.4 million cases of nonmelanoma skin cancer are treated. The annual cost of treating skin cancers in the U.S. is estimated at $8.1 billion. Treatment and prevention of skin cancer is a significant health care challenge. Physical Sciences Inc. (PSI), in collaboration with Dartmouth College and C ...

    SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
  9. Low-Cost Decoy

    SBC: Integrated Solutions for Systems, Inc.            Topic: AF22ZPDCSO2

    IS4S proposes to build a system model (SysML) in Cameo for a Low-Cost Decoy (LCD) compatible with the BRU-61 four-place carriage system.  The motivation and focus of this phase II SBIR is squarely on two of Secretary Kendall’s Operational Imperatives: 3. Defining the Next Generation Air Dominance (NGAD) System-of-Systems; “NGAD must be more than just the next crewed fighter jet. It’s a pro ...

    SBIR Phase II 2022 Department of DefenseAir Force
  10. Testing a male oral contraceptive targeting Eppin

    SBC: EPPIN PHARMA INC            Topic: NICHD

    The global contraceptives market was valued at $billion inand is expected to grow at a CAGR offromtoto reach an estimated value of $billion inThe contraceptive market consists of short term methods such as condoms and oral contraceptionlong term methods including implants and IUDsand permanent methods such as tubal ligations and vasectomiesEppin Pharmaandapos s product has a unique set of characte ...

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government